Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis
Ying‐Nai Wang, Heng‐Huan Lee, Jennifer L. Hsu, et al.
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 135

Showing 26-50 of 135 citing articles:

Biomarkers for response to immunotherapy in hepatobiliary malignancies
Zhifei Lin, Lun‐Xiu Qin, Jinhong Chen
Hepatobiliary & pancreatic diseases international (2022) Vol. 21, Iss. 5, pp. 413-419
Closed Access | Times Cited: 23
Crosstalk between PD-L1 and Jak2-Stat3/ MAPK-AP1 signaling promotes oral cancer progression, invasion and therapy resistance
Arpita Jha, Manzar Alam, Tanushree Kashyap, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110894-110894
Closed Access | Times Cited: 14
Resistance to anti-PD-1/anti-PD-L1: galectin-3 inhibition with GB1211 reverses galectin-3-induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1
Joseph Mabbitt, Ian D. Holyer, James A. Roper, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Stabilization of EREG via STT3B-mediated N-glycosylation is critical for PDL1 upregulation and immune evasion in head and neck squamous cell carcinoma
Shengming Xu, Haifeng Wang, Yu Zhu, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
N-linked glycosylation of PD-L1/PD-1: an emerging target for cancer diagnosis and treatment
Zhiyun Duan, Runhan Shi, Bo Gao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Disrupting EDEM3‐induced M2‐like macrophage trafficking by glucose restriction overcomes resistance to PD‐1/PD‐L1 blockade
Shaoyong Peng, Minhao Wu, Yan Qian, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access
Modulation of N-glycosylation in the PD-1: PD-L1 axis as a strategy to enhance cancer immunotherapies
Monika Granica, Gustaw Laskowski, Paweł Link-Lenczowski, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189274-189274
Open Access
Post-translational modifications in hepatocellular carcinoma: unlocking new frontiers in immunotherapy
Yuexian Piao, Naicui Zhai, Xiaoling Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Proteogenomic characterization reveals tumorigenesis and progression of lung cancer manifested as subsolid nodules
Hang Su, Lixia Chen, Jun Wu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Interferons and Toxoplasma shape PD-L1 regulation in retinal barrier cells: The critical role of proteases
Benjamin Geiller, Cintia Cevallos, Iuliia Tsybenko, et al.
Research Square (Research Square) (2025)
Closed Access
Post-translational modifications of immune checkpoints: unlocking new potentials in cancer immunotherapy
Qiongjie Hu, Yueli Shi, Huang Wang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Programmed Cell Death Ligand as a Biomarker for Response to Immunotherapy: Contribution of Mass Spectrometry-Based Analysis
Marco Agostini, Pietro Traldi, Mahmoud Hamdan
Cancers (2025) Vol. 17, Iss. 6, pp. 1001-1001
Open Access
Glycans as shapers of tumour microenvironment: A sweet driver of T‐cell‐mediated anti‐tumour immune response
Ângela Fernandes, Catarina M. Azevedo, Mariana C. Silva, et al.
Immunology (2022) Vol. 168, Iss. 2, pp. 217-232
Open Access | Times Cited: 22
Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day
Brigida Anna Maiorano, Ugo De Giorgi, Davide Ciardiello, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 411-411
Open Access | Times Cited: 20
Dual Effect of Combined Metformin and 2-Deoxy-D-Glucose Treatment on Mitochondrial Biogenesis and PD-L1 Expression in Triple-Negative Breast Cancer Cells
Jernej Repas, Mateja Zupin, Maja Vodlan, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1343-1343
Open Access | Times Cited: 19
CEBPB regulates the migration, invasion and EMT of breast cancer cells by inhibiting THBS2 expression and O-fucosylation
Liqiang Qi, Bo Sun, Beibei Yang, et al.
Human Molecular Genetics (2023) Vol. 32, Iss. 11, pp. 1850-1863
Closed Access | Times Cited: 12
Tissue Age Affects Antigenicity and Scoring for the 22C3 Immunohistochemistry Companion Diagnostic Test
Aileen I. Fernandez, Patricia Gaule, David L. Rimm
Modern Pathology (2023) Vol. 36, Iss. 7, pp. 100159-100159
Open Access | Times Cited: 12
Exploiting Autophagy-Dependent Neoantigen Presentation in Tumor Microenvironment
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, et al.
Genes (2023) Vol. 14, Iss. 2, pp. 474-474
Open Access | Times Cited: 11
Benefits and Pitfalls of a Glycosylation Inhibitor Tunicamycin in Therapeutic Implication of Cancers
Snigdha Banerjee, Affan A. Ansari, Sunil P. Upadhyay, et al.
(2024)
Open Access | Times Cited: 4
The significance of targeting lysosomes in cancer immunotherapy
Yanxin Xu, Bo Shao, Yafeng Zhang
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Glycosylation in cancer as a source of biomarkers
Sara Khorami-Sarvestani, Samir Hanash, Johannes F. Fahrmann, et al.
Expert Review of Proteomics (2024) Vol. 21, Iss. 9-10, pp. 345-365
Closed Access | Times Cited: 4
An engineered PD1-Fc fusion produced in N. benthamiana plants efficiently blocks PD1/PDL1 interaction
Shiva Izadi, Rafaela Abrantes, Simon Gumpelmair, et al.
Plant Cell Reports (2025) Vol. 44, Iss. 4
Open Access
In Situ Visualization of PD-L1-Specific Glycosylation on Tissue Sections
Mengjiao Huang, Lin Zhu, Siyin Kang, et al.
Analytical Chemistry (2021) Vol. 93, Iss. 48, pp. 15958-15963
Closed Access | Times Cited: 23
Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer
Jong‐Ho Cha, Li-Chuan Chan, Ying‐Nai Wang, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 4, pp. 101817-101817
Open Access | Times Cited: 18
Advances in the Immunomodulatory Properties of Glycoantigens in Cancer
Valeria da Costa, Teresa Freire
Cancers (2022) Vol. 14, Iss. 8, pp. 1854-1854
Open Access | Times Cited: 18

Scroll to top